Efficacy and safety of proton pump inhibitors versus vonoprazan in treatment of erosive esophagitis: A PRISMA-compliant systematic review and network meta-analysis

Proton-pump inhibitors (PPIs) and vonoprazan are recommended as first-line therapies for erosive esophagitis (EE). However, it is uncertain how the magnitude of efficacy and safety of first-line therapy, the choice of individual PPIs or vonoprazan in the treatment of EE remains controversial. This s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Sensen, Deng, Weishang, Xie, Zeyu, Chen, Jisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704910/
https://www.ncbi.nlm.nih.gov/pubmed/36451489
http://dx.doi.org/10.1097/MD.0000000000031807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704910/
https://www.ncbi.nlm.nih.gov/pubmed/36451489
http://dx.doi.org/10.1097/MD.0000000000031807

Ejemplares similares